UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
Embraer Boosts Aircraft Deliveries in Q4 2025, Signaling Strong Growth Into 2026 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns 
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone 
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
BOSTON, Oct. 24, 2017 -- Charlesbank Capital Partners announced the closing of Charlesbank Equity Fund IX, LP (“Fund IX”) at its hard cap of $2.75 billion in limited partner commitments, concluding a fundraising process that launched in June. Investors in the fund include leading public and corporate pension funds, endowments, foundations, family offices, sovereign wealth vehicles and financial institutions.
Founded in 1998, Charlesbank is a middle-market private equity firm with offices in Boston and New York. The firm expects to deploy between $50 million and $250 million in each Fund IX portfolio investment, and will also make opportunistic credit investments. Additionally, an overage allocation program established simultaneously with commitments from Fund IX investors will allow Charlesbank to commit larger amounts per transaction if needed. The firm will continue its long-established strategy of generalist and opportunistic investing in partnership with strong management teams, with a focus on the following core verticals: consumer, industrial, industrial services and distribution, TMT and business services.
“The in-depth dialogue with our limited partners through the fundraising process always results in enriching perspectives that help make us a better steward of their capital, and we are truly gratified by the strong support we have received,” said Michael Choe, Charlesbank’s CEO. “We are as committed as ever to deliver continued strong results by maintaining the disciplined and fundamentals-focused investment approach that has guided Charlesbank since its inception.”
“We are privileged to have such a world-class group of limited partners, and we are especially grateful for the ongoing support of our returning investors,” said Michael Eisenson, Managing Director and Co-Chairman of Charlesbank. “Many of them have been with us for multiple funds, and their long-term conviction in Charlesbank has been key to our success.”
Over its 19-year history, Charlesbank has invested more than $4.5 billion in more than 50 middle-market companies. The firm has offices in Boston and New York and a team of 58 people.
Goodwin Procter served as outside fund counsel.
For more information on Charlesbank, visit www.charlesbank.com.
Contact: Maura M. Turner
617-619-5457
[email protected]
